Agen ophthalmic anti-angiogenik

Apa iku agen ophthalmic Anti-angiogenic?

Agen ophthalmic anti-angiogenic tumindak minangka antagonis vascular endothelial growth factor (VEGF). Nalika sel pigmen retina dadi iskemik lan garing munggah VEGF stimulates generasi saka pembuluh getih anyar dening proses disebut neovascularization. Sajrone generasi pembuluh getih anyar ing retina, yen pembuluh getih ora ngasilake kanthi bener, bisa nyebabake bocor. Iki bisa nyebabake mundhut sesanti.

Agen ophthalmic anti-angiogenik digunakake kanggo mungkasi neovaskularisasi ing degenerasi makula sing gegandhengan karo umur.

Dhaptar obat karo Agen ophthalmic anti-angiogenik

Jeneng Obat
Aflibercept
Generic name: Aflibercept
Aflibercept ophthalmic
Generic name: Aflibercept Ophthalmic
Avacincaptad pegol
Generic name: Avacincaptad Pegol
Beovu
Generic name: Brolucizumab-dbll
Brolucizumab ophthalmic
Generic name: Brolucizumab Ophthalmic
Brolucizumab-dbll
Generic name: Brolucizumab-dbll
Byooviz
Generic name: Ranibizumab (ophthalmic)
Cimerli
Generic name: Ranibizumab-eqrn (ophthalmic)
Cimerli (Ranibizumab Intraocular)
Generic name: Ranibizumab
Cimerli (Ranibizumab-eqrn Intraocular)
Generic name: Ranibizumab-eqrn
Eylea
Generic name: Aflibercept Ophthalmic
Eylea Pre-filled Syringe
Generic name: Aflibercept Ophthalmic
Faricimab-svoa
Generic name: Faricimab-svoa
Izervay
Generic name: Avacincaptad Pegol
Lucentis
Generic name: Ranibizumab (ophthalmic)
Macugen
Generic name: Pegaptanib Ophthalmic Injection
Pegaptanib
Generic name: Pegaptanib
Ranibizumab
Generic name: Ranibizumab
Ranibizumab ophthalmic
Generic name: Ranibizumab (ophthalmic)
Ranibizumab-eqrn
Generic name: Ranibizumab-eqrn
Susvimo
Generic name: Ranibizumab
Vabysmo
Generic name: Faricimab-svoa

Disclaimer

Kabeh upaya wis ditindakake kanggo mesthekake yen informasi sing diwenehake dening Drugslib.com akurat, nganti -tanggal, lan lengkap, nanging ora njamin kanggo efek sing. Informasi obat sing ana ing kene bisa uga sensitif wektu. Informasi Drugslib.com wis diklumpukake kanggo digunakake dening praktisi kesehatan lan konsumen ing Amerika Serikat lan mulane Drugslib.com ora njamin sing nggunakake njaba Amerika Serikat cocok, kajaba khusus dituduhake digunakake. Informasi obat Drugslib.com ora nyetujoni obat, diagnosa pasien utawa menehi rekomendasi terapi. Informasi obat Drugslib.com minangka sumber informasi sing dirancang kanggo mbantu praktisi kesehatan sing dilisensi kanggo ngrawat pasien lan / utawa nglayani konsumen sing ndeleng layanan iki minangka tambahan, lan dudu pengganti, keahlian, katrampilan, kawruh lan pertimbangan babagan perawatan kesehatan. praktisi.

Ora ana bebaya kanggo kombinasi obat utawa obat sing diwenehake kanthi cara apa wae kudu ditafsirake kanggo nuduhake yen obat utawa kombinasi obat kasebut aman, efektif utawa cocok kanggo pasien tartamtu. Drugslib.com ora nanggung tanggung jawab kanggo aspek kesehatan apa wae sing ditindakake kanthi bantuan informasi sing diwenehake Drugslib.com. Informasi sing ana ing kene ora dimaksudake kanggo nyakup kabeh panggunaan, pituduh, pancegahan, bebaya, interaksi obat, reaksi alergi, utawa efek samping. Yen sampeyan duwe pitakon babagan obat sing sampeyan gunakake, takon dhokter, perawat utawa apoteker.

Tembung kunci populer